Drugs / levodopa/carbidopa
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01636037 | Sep 2012 → Dec 2015 | schizophrenia | Centre for Addiction and Mental Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | levodopa/carbidopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01636037 ↗ |
| Route | Oral | “with oral L-Dopa (levodopa/carbidopa)” NCT01636037 ↗ |